Emily Potts, PhD, MBA

Emily Potts is Operations Manager and Science Strategy Lead at Freedom Biosciences where she works across clinical development, regulatory strategy, and program operations, contributing to the advancement of the company’s neuropsychiatric pipeline. Emily completed her doctoral research in cellular and molecular neuroscience, studying various mechanisms of neurodegenerative diseases using new approach methodologies with iPSC models, and has complemented this with business training in strategy and operations. She holds a PhD in Neuroscience and an MBA from the University of Rhode Island.